Concepedia

Michael Stipanov

MS

Statistics

Publications

4

Citations

325

H-Index

4

Active since

1999

Affiliations

Vanderbilt University Medical Center(Current)

Vanderbilt University

Vanderbilt-Ingram Cancer Center

Michael Stipanov is an author at Vanderbilt University Medical Center specializing in oncology, medicine, and immunotherapy.

Publications per year

1999–2011

4

Publications

4

Immunization With Mutant<i>p53</i>- and<i>K-ras</i>–Derived Peptides in Cancer Patients: Immune Response and Clinical Outcome

David P. Carbone, I. Frank Ciernik, Michael J. Kelley et al. · Journal of Clinical Oncology · 2005 · 169 citations · Full text

, , +17

Dendritic cells transduced with wild-type p53 gene elicit potent anti-tumour immune responses

Tadao Ishida, Sunil Chada, Michael Stipanov et al. · Clinical & Experimental Immunology · 1999 · 79 citations · Full text

, , +16

Combined Modality Treatment With Chemotherapy, Radiation Therapy, Bevacizumab, and Erlotinib in Patients With Locally Advanced Squamous Carcinoma of the Head and Neck

John D. Hainsworth, David R. Spigel, F. Anthony Greco et al. · The Cancer Journal · 2011 · 66 citations

, , +15

A Phase I Study of Vitamin E, 5-Fluorouracil and Leucovorin for Advanced Malignancies

Charles D. Blanke, Michael Stipanov, Jason D. Morrow et al. · Investigational New Drugs · 2001 · 11 citations

, , +13

1–4 of 4